According to a new report, the global contract research organization (CRO) market was valued at approximately USD 34.12 billion in 2018, and is expected to generate around USD 55.16 billion by 2025, at a CAGR of around 7.10% between 2019 and 2025. The main factors expected to drive the CRO market in the coming years include an increasing number of clinical trials and growing R&D expenditure. (Zion Market Research)
Current Feature
CRA burnout in clinical research
By Eleanor Houston, Senior CRA, Industry Gain insight into the factors of CRA burnout in clinical research from the 2018 PharmaTimes Clinical Researcher of the Year New CRA. It is no secret that CRA turnover is a huge issue in the clinical research industry. It is not uncommon for sponsors Read more
Current Feature
Clinical Trials in Australia: The Competitive Edge
Article by Teresa C. Gallagher, Ph.D., M.S. On November 13, 2018, BIOCOM’s San Diego office offered a panel presentation to its members on “Clinical Trials in the Asia Pacific Region: The Competitive Edge.” BIOCOM is a trade association and advocate for California’s life science sector, with offices in San Diego, Read more
Doctors frustrated working with CROs
Over 132,000 trials are listed on the ClinicalTrials.gov database. Many of these are industry-sponsored, for which drugmakers often outsource functions to one of more contract research organizations (CROs). Doctors have publicly expressed frustration with experiences they have had in clinical trials related to working with CROS, including poor communication, busywork, and unreliable technology. Ken Getz, a CRO industry expert, says the sponsor can be part of the problem as well. (MedCityNews)